Twist and torque in the cellular nanocosmos: Diez group detects biophysical forces of molecular motors in 3D
Three million euro for new methodology in personalised medicine
Dresden Innovation Centre B CUBE and Potsdam Innovation Centre innoFSPEC receive funding from the federal government
The Center for Molecular Bioengineering (B CUBE) of TU Dresden and the Center for innovative fiber optic spectroscopy and sensors (innoFSPEC) of the University of Potsdam, both are parts of the Federal Ministry of Education and Research (BMBF) centers for innovation competence (ZIK) initiative, will receive BMBF funding of approximately three million euros for the project „Optical Cell Diagnosis and Manipulation” (OptiZeD). Innovative methods for personalised medicine will be developed with the help of a novel, miniaturized multiparameter biosensor system (MBS).
"We want to be able to track cell responses to a stimulus in real time and down to the individual cell. If this succeeds, the OptiZeD MBS could be used as an analytical, diagnostic and therapeutic tool", says project leader Michael Schlierf, Professor of Molecular Biophysics at B CUBE at TU Dresden. “This will enable us to meet the challenges of personalised medical treatment”, is added by project leader Prof. Ilko Bald, Professor for Hybrid Nanostructures.
Fibre sensor technology will help in the diagnosis of diseases, while new materials and suitable methods are needed to deliver drugs to certain sites of disease tissue, in order to combat disease in a targeted and local manner. The fibre-optic detection of biomarkers represents a method for diagnosing diseases in vivo, meaning directly in the patient, in combination with localized treatment.
The two project partners complement each other perfectly with regard to their competences. Only through the interdisciplinary team consisting of Dr. Claudia Pacholski (Functional Nanomaterials), Prof. Ilko Bald (Hybrid Nanostructures), Prof. Yixin Zhang (Biomolecular Interactions), Prof. Stefan Diez (BioNanoTools) and Prof. Michael Schlierf (Molecular Biophysics), the therapeutic tools can be developed. The innoFSPEC has experience in the development of fibre optic methods and the B CUBE brings expertise in fluorescence technologies and biomaterials. Together, they can tackle the challenges of optical cell diagnosis and present tangible perspectives for personalized medicine.
Vision of the MetaZIKs OptiZeD for the development of an integral multiparameter biosensor system (MBS) © Yixin Zhang
Further media inquiries:
Prof. Ilko Bald
Tel: +49 (0) 331 977 5238
Prof. Michael Schlierf
Tel: +49 (0) 351 463 43050
Webpage: www.tu-dresden.de/bcubeBack to News Ticker